Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-07-18
- Last Posted Date
- 2016-12-22
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 27
- Registration Number
- NCT00065130
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Santa Barbara, California, United States
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-03-20
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 11
- Registration Number
- NCT00056589
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath